You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Topic 378: mPROS: Mobile PRO-CTCAE Administration System for Post-Radiation Toxicities

    SBC: Intelligent Automation, Inc.            Topic: NCI

    The problems this contract is addressing include making it easy for patients to report toxicities after radiation therapy so that they can be timely and accurate and so that they can be incorporated into a medical database for use by medical professionals. This would allow the app to recommend (when appropriate), and for clinicians to intervene, with appropriate treatments and will lead to better ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  2. Topic 369: DRUG DELIVERY SYSTEM TO SAVE HEARING DURING PEDIATRIC CHEMOTHERAPY REGIMENS

    SBC: Otomagnetics, Inc.            Topic: NCI

    Our company has invented a magnetic drug delivery device that we intend to develop to enable prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin chemotherapy regimens can lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing loss in kids has a dramatic impact on the ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  3. TOPIC 363- Caregiver Buddy: Leveraging Standards to Help Cancer Caregivers and Clinicians

    SBC: CARE PROGRESS LLC            Topic: NCI

    This research project seeks to create innovative software that aids cancer patient caregivers,by improving their ability to access patient information, communicate with clinicians, and provide peer support. We seek to leverage the insights of stakeholders and subject matter experts as well as industry standards to enhance a caregiver facing SmartPhone app and related software developed in Phase I ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  4. An Engineered Nanoimmunotherapy for Melanoma

    SBC: IMMUNOBLUE, LLC            Topic: NCI

    PROJECT SUMMARY Melanoma is one of the most prevalent cancers and is estimated to account for overdeaths inin the United States aloneAlthough highly curable when detected earlytheyear survival rates decline precipitously for patients with regionaland metastaticmelanoma indicating a lack of efficacy of conventional therapiesand a strong need for novel therapies for this patient populationIn respons ...

    STTR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  5. Papillomavirus-like Particles (VLP) as Broad Spectrum Human Papillomavirus (HPV) Vaccines

    SBC: PATHOVAX LLC            Topic: NIAID

    Project Summary The goal of this SBIR Fast Track project is to further the commercialization of PathoVax s bi valent RGVaxTM as a broad spectrum Human PapillomavirusHPVvaccine that targets all clinically relevant HPVsCurrent HPV vaccines provide type restricted protection that focuses only on sexually transmitted HPVs resulting in an unexpected STD stigma that directly affects uptake ratesBy targe ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  6. Building an evidentiary case for circulating GHBP as a biomarker for drug-associated stunting of growth

    SBC: REVERAGEN BIOPHARMA, INC.            Topic: NICHD

    There is increasing interest in the use of biomarkers in clinical drug developmentwith much of thest Century Cures Act focused on encouraging this approachIdeallybiomarkers could provide and acute and objective read out of drug mechanism of actionpharmacodynamic biomarkersor prediction of later clinical benefit or harmsurrogate outcome measureHoweververy few biomarkers have been validated for rout ...

    STTR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  7. Improved RSV F Vaccine Candidates

    SBC: BIOLOGICAL MIMETICS, INC.            Topic: NIAID

    Abstract Respiratory syncytial virusRSVa viral agent that causes severe respiratory illnessinfects a large percentage of infants and children worldwide by the age of threeEHeylen et alAccording to the CDCRSV is responsible for overhospitalizations andmillion outpatient visits among children younger thanyears as well ashospitalizations anddeaths among the elderly in the US aloneEKMilleret alAfter m ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  8. Fast, flexible, and economical system for affinity-tag protein purification and tag removal

    SBC: POTOMAC AFFINITY PROTEIN LLC            Topic: 300

    Project SummaryOur long term objective is to commercialize a fastsimpleflexibleand economical system for affinity tag protein purification and tag removalThis technology was developed as a result of NIH funded studies on the foldingstability and enzymology of the Bacillus protease subtilisinThe transformative purification technology combines three componentsa regulatedhighly specific proteasePsubt ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  9. Noninvasive placement and activation of deep-brain stimulating magnetic particles for reduction of drug-seeking behaviors

    SBC: WEINBERG MEDICAL PHYSICS, INC.            Topic: NIDA

    Abstract Deep brain stimulationDBSwith implantable electrodes has been used for reduction of ethanol abuse and drug seeking behaviors in EuropeThe use of such deep brain stimulation procedures has been problematic because of concerns about invasiveness of the procedureApplicant has developed a new noninvasive method of transporting magnetic particles directly to target sites within the brainWe pro ...

    STTR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  10. Development, GMP manufacture, and quality control release of a triple knock out genetically attenuated Plasmodium falciparum sporozoite vaccine

    SBC: SANARIA INC.            Topic: NIAID

    The overarching goal of this project is to develop a highly effective vaccine for prevention of Plasmodium falciparumPfmalaria based on a genetically attenuatedGAtriple gene knockout sporozoiteSPZstage parasite that is asepticpurified and safe for parenteral injectionIn this Phase I applicationwe propose to optimize the manufacturing processes for the vaccineSanariaPfSPZ GAand producelot suitable ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government